Calmy Alexandra
Calmy Alexandra
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, immune system disorder, immunodeficiency disease, inborn error of immunity, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-02-18 | NCT07406217 | |
| Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls | RZV Vaccine (Shingrix ®) | Active, not recruiting | Phase 4 | 2025-09-05 | NCT05575830 |